Skip to main content

Want a detailed portfolio tracker?

Celcuity (CELC) P/E (2017 - 2026)

Celcuity (CELC) P/E from Oct 2, 2017 to Jun 3, 2026. The TTM Celcuity (CELC) P/E is -20.57. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Celcuity (CELC)

YearP/EChange
2026-20.57-13.19%
2025-23.69+466.95%
2024-4.18-26.52%
2023-5.69-3.41%
2022-5.89-2.11%
2021-6.02-43.04%
2020-10.56-28.30%
2019-14.73-54.65%
2018-32.48-70.08%
2017-108.55N/A

Comparison Celcuity (CELC) P/E with competitors

Celcuity (CELC) P/E is -20.57.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.10-100.50%
ENLVEnlivex Therapeutics Ltd0.15-100.73%
FGENFibroGen Inc0.24-101.17%
TRAWTraws Pharma Inc0.47-102.30%
FBIOFortress Biotech Inc0.71-103.43%
CHRSCoherus Biosciences Inc0.98-104.76%
ORMPOramed Pharmaceuticals Inc1.47-107.16%
AGENAgenus Inc2.05-109.96%
VIVSVivoSim Labs Inc2.54-112.33%
INVAInnoviva Inc3.19-115.50%
CRMDCorMedix Inc3.65-117.73%
ABEOAbeona Therapeutics Inc4.20-120.44%
VXRTVaxart Inc4.26-120.72%
CVACCureVac N.V.4.45-121.61%
SRPTSarepta Therapeutics Inc4.62-122.48%
GLPGGalapagos NV4.86-123.62%
RIGLRigel Pharmaceuticals4.92-123.92%
ZVRAZevra Therapeutics Inc4.97-124.18%
ABUSArbutus Biopharma Corp5.69-127.68%
CGENCompugen Ltd7.38-135.90%
AUPHAurinia Pharmaceuticals Inc9.25-144.98%
ACADAcadia Pharmaceuticals Inc9.59-146.62%
OMEROmeros Corporation9.88-148.05%
PLXProtalix BioTherapeutics Inc9.91-148.18%
SPROSpero Therapeutics Inc10.73-152.19%
ADMAAdma Biologics Inc11.33-155.09%
SVASinovac Biotech Ltd11.44-155.60%
TBPHTheravance Biopharma Inc11.78-157.26%
HRMYHarmony Biosciences Holdings Inc12.18-159.22%
TGTXTG Therapeutics Inc13.18-164.08%
INCYIncyte Corp13.38-165.06%
SABSSAB Biotherapeutics Inc14.06-168.35%
XOMAXOMA Corp14.95-172.67%
REGNRegeneron Pharmaceuticals Inc14.98-172.84%
PBYIPuma Biotechnology Inc15.05-173.18%
EXELExelixis Inc15.79-176.80%
NAGENiagen Bioscience Inc16.35-179.52%
CPRXCatalyst Pharmaceuticals Inc17.34-184.33%
MDXGMimedx Group Inc17.38-184.48%
ARGXArgen X SE23.07-212.18%
HALOHalozyme Therapeutics Inc23.20-212.80%
XOMAOXOMA Corp25.34-223.23%
VRTXVertex Pharmaceuticals Inc25.66-224.74%
XOMAPXOMA Corp25.67-224.81%
CTMXCytomX Therapeutics Inc25.70-224.95%
ASNDAscendis Pharma A/S26.35-228.14%
RPRXRoyalty Pharma plc - Class A27.50-233.69%
SLNOSoleno Therapeutics Inc29.02-241.08%
LGNDLigand Pharmaceuticals Inc - Class B30.19-246.77%
BMRNBiomarin Pharmaceutical Inc37.51-282.36%
APLSApellis Pharmaceuticals Inc39.02-289.73%
KRYSKrystal Biotech Inc39.70-293.01%
GMABGenmab40.20-295.47%
ONCBeiGene Ltd67.03-425.89%
TECHBio-Techne Corp68.59-433.52%
VCELVericel Corp80.63-492.03%
PHARPharming Group N.V.87.74-526.60%
ALNYAlnylam Pharmaceuticals Inc124.93-707.44%
TLXTelix Pharmaceuticals Ltd139.89-780.16%
CORTCorcept Therapeutics Inc158.39-870.11%